BHST

BioHarvest Sciences Inc.
CAPPED RATING

BioHarvest Sciences Inc. (BHST) is rated C (2.4/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D-). The rating has held at C for 6 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
B-
Factor Score 3.0 / 5.0
Growth
B
Factor Score 3.4 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
D-
Factor Score 0.9 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -3.8
EV / EBITDA -6.7
Rev Growth YoY 3.8%
Gross Margin 59.0%
Price Return 3M -34.6%
Price Return 12M -81.1%
Catalyst Signal 0.00
Market Cap $31.3M
TTM Revenue $35.5M
Price / Sales 0.9
ROE -142.5%

Historical Factor Score Progression

Held C for 6 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B- (3.0) B (3.4) C- (1.9) D- (0.9) C+ (2.6) C (2.4)
2026-11-10 B- (3.0) B (3.4) C- (1.9) D (1.4) C+ (2.6) C (2.5)
2026-11-03 B- (3.0) B (3.4) C- (2.0) D- (1.0) C+ (2.6) C (2.4)
2026-10-27 B- (3.0) B (3.5) C- (1.9) D (1.3) C (2.4) C (2.4)
2026-10-20 B- (3.0) B (3.5) C- (1.9) D- (1.1) C (2.3) C (2.4)
Page 1 of 4